Providing for consideration of the bill (H.R. 4566) to amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act; providing for consideration of the bill (H.R. 5247) to authorize the use of eligible investigational drugs by eligible patients who have been diagnosed with a stage of a disease or condition in which there is reasonable likelihood that death will occur within a matter of months, or with another eligible illness, and for other purposes; and for other purposes.
USA115th CongressHRES-787| House
| Updated: 3/20/2018
Michael C. Burgess
Republican Representative
Texas
Rules Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Sets forth the rule for consideration of the bill (H.R. 4566) to amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act; providing for consideration of the bill (H.R. 5247) to authorize the use of eligible investigational drugs by eligible patients who have been diagnosed with a stage of a disease or condition in which there is reasonable likelihood that death will occur within a matter of months, or with another eligible illness, and for other purposes.
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Placed on the House Calendar, Calendar No. 133.
The House Committee on Rules reported an original measure, H. Rept. 115-613, by Mr. Burgess.
The resolution provides for one hour of debate on each bill. The resolution makes in order only the further amendment to H.R. 4566 printed in the report. No further amendments on either bill are made in order. Section 3 of the resolution makes it in order to consider any resolution reported from the Rules Committee on the day it is reported through the legislative day of March 23, 2018. Section 4 grants suspension authority on the legislative days of March 22, 2018 and March 23, 2018. Section 5 of the resolution amends section 3(a) of H. Res. 5.
Considered as privileged matter. (consideration: CR H1704-1710)
DEBATE - The House proceeded with one hour of debate on H. Res. 787.
POSTPONED PROCEEDINGS - At the conclusion of debate on H. Res. 787, the Chair put the question on ordering the previous question and by voice vote announced that the ayes had prevailed. Mr. Hastings demanded the yeas and nays, and the Chair postponed further proceedings on the question of ordering the previous question until later in the legislative day.
Considered as unfinished business.
On ordering the previous question Agreed to by the Yeas and Nays: 233 - 181 (Roll no. 117). (consideration: CR H1704; text: CR H1704)
View VoteOn agreeing to the resolution Agreed to by recorded vote: 225 - 183 (Roll no. 118). (text: CR H1704)
View VoteMotion to reconsider laid on the table Agreed to without objection.
Congress
House of RepresentativesLegislative rules and procedure
Providing for consideration of the bill (H.R. 4566) to amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act; providing for consideration of the bill (H.R. 5247) to authorize the use of eligible investigational drugs by eligible patients who have been diagnosed with a stage of a disease or condition in which there is reasonable likelihood that death will occur within a matter of months, or with another eligible illness, and for other purposes; and for other purposes.
USA115th CongressHRES-787| House
| Updated: 3/20/2018
Sets forth the rule for consideration of the bill (H.R. 4566) to amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act; providing for consideration of the bill (H.R. 5247) to authorize the use of eligible investigational drugs by eligible patients who have been diagnosed with a stage of a disease or condition in which there is reasonable likelihood that death will occur within a matter of months, or with another eligible illness, and for other purposes.
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Placed on the House Calendar, Calendar No. 133.
The House Committee on Rules reported an original measure, H. Rept. 115-613, by Mr. Burgess.
The resolution provides for one hour of debate on each bill. The resolution makes in order only the further amendment to H.R. 4566 printed in the report. No further amendments on either bill are made in order. Section 3 of the resolution makes it in order to consider any resolution reported from the Rules Committee on the day it is reported through the legislative day of March 23, 2018. Section 4 grants suspension authority on the legislative days of March 22, 2018 and March 23, 2018. Section 5 of the resolution amends section 3(a) of H. Res. 5.
Considered as privileged matter. (consideration: CR H1704-1710)
DEBATE - The House proceeded with one hour of debate on H. Res. 787.
POSTPONED PROCEEDINGS - At the conclusion of debate on H. Res. 787, the Chair put the question on ordering the previous question and by voice vote announced that the ayes had prevailed. Mr. Hastings demanded the yeas and nays, and the Chair postponed further proceedings on the question of ordering the previous question until later in the legislative day.
Considered as unfinished business.
On ordering the previous question Agreed to by the Yeas and Nays: 233 - 181 (Roll no. 117). (consideration: CR H1704; text: CR H1704)
View VoteOn agreeing to the resolution Agreed to by recorded vote: 225 - 183 (Roll no. 118). (text: CR H1704)
View VoteMotion to reconsider laid on the table Agreed to without objection.
Michael C. Burgess
Republican Representative
Texas
Rules Committee
Congress
Related Bills
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
House of RepresentativesLegislative rules and procedure